Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Caracciolo

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
The Science of the Total Environment|December 18, 2015
Co-evolution of hydrological components under climate change scenarios in the Mediterranean areaF Viola, A Francipane, D Caracciolo, et al.
Blood|February 1, 1989
Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitorsD Ferrero, C Tarella, R Badoni, et al.
Haematologica|March 1, 1990
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapseC Tarella, E Gallo, D Ferrero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell linesD Santoli, Y C Yang, S C Clark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomasC Tarella, P Gavarotti, D Caracciolo, et al.
Blood|January 15, 1997
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autograftingP Corradini, M Astolfi, C Cherasco, et al.
Leukemia Research|January 1, 1990
Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modalityC Tarella, P Pregno, E Gallo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell lineM Valtieri, D J Tweardy, D Caracciolo, et al.
Haematologica|January 1, 1990
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myelomaA Pileri, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|March 24, 1998
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costsC Tarella, C Castellino, F Locatelli, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
The Science of the Total Environment|December 18, 2015
Co-evolution of hydrological components under climate change scenarios in the Mediterranean areaF Viola, A Francipane, D Caracciolo, et al.
Blood|February 1, 1989
Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitorsD Ferrero, C Tarella, R Badoni, et al.
Haematologica|March 1, 1990
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapseC Tarella, E Gallo, D Ferrero, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell linesD Santoli, Y C Yang, S C Clark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomasC Tarella, P Gavarotti, D Caracciolo, et al.
Blood|January 15, 1997
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autograftingP Corradini, M Astolfi, C Cherasco, et al.
Leukemia Research|January 1, 1990
Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modalityC Tarella, P Pregno, E Gallo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell lineM Valtieri, D J Tweardy, D Caracciolo, et al.
Haematologica|January 1, 1990
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myelomaA Pileri, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|March 24, 1998
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costsC Tarella, C Castellino, F Locatelli, et al.
Pageof 5